Approval · Notice of Compliance 9436 · 2008
INTELENCE: Notice of Compliance 9436
Issued March 27, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9436
- Date
- March 27, 2008
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Human immunodeficiency virus (hiv) non-nucleoside reverse transcriptase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTELENCE | 02306778 | Marketed |
Medicinal ingredients
- ETRAVIRINE 100 MG per TAB